Turgut, M.
Moreau, P.
Dimopoulos, M.
Mikhael, J.
Yong, K.
Capra, M.
Facon, T.
Hajek, R.
Spicka, I.
Risse, M.
Asset, G.
Macé, S.
Martin, T.
This article is maintained by: Elsevier
Article Title: Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-label study
Journal Title: Hematology, Transfusion and Cell Therapy
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2020.09.093
Content Type: simple-article
Copyright: Copyright © 2020 Published by Elsevier Editora Ltda.